| Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency A Das, U Tabori, LC Sambira Nahum, NB Collins, R Deyell, R Dvir, ... Clinical Cancer Research, CCR-23-0411, 2023 | 16 | 2023 |
| Genomic microsatellite signatures identify germline mismatch repair deficiency and risk of cancer onset J Chung, L Negm, V Bianchi, L Stengs, A Das, ZA Liu, S Sudhaman, ... Journal of Clinical Oncology 41 (4), 766-777, 2023 | 14 | 2023 |
| Single-strand mismatch and damage patterns revealed by single-molecule DNA sequencing MH Liu, B Costa, U Choi, RC Bandler, E Lassen, M Grońska-Pęski, ... bioRxiv, 2023 | 5 | 2023 |
| Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study AB Ercan, M Aronson, NR Fernandez, Y Chang, A Levine, ZA Liu, L Negm, ... The Lancet Oncology 25 (5), 668-682, 2024 | 2 | 2024 |
| Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium A Das, NR Fernandez, A Levine, V Bianchi, LK Stengs, J Chung, L Negm, ... Cancer Discovery 14 (2), 258-273, 2024 | 2 | 2024 |
| MDB-12. TRANS-SPECIES ANALYSIS OF REPLICATION-REPAIR DEFICIENT (RRD) MEDULLOBLASTOMA AND RESPONSE TO IMMUNE-CHECKPOINT INHIBITION: AN IRRDC REPORT A Das, NR Fernandez, A Levine, K Smith, E Wang, M Galati, Z Aamir, ... Neuro-Oncology 25 (Suppl 1), i64, 2023 | 1 | 2023 |
| HGG-27. The impact of mismatch repair deficiency on gliomas in children, adolescents, and young adults; a report from the IRRDC and the glioma task force L Negm, L Nobre, J Bennett, J Chung, M Komosa, N Fernandez, M Ku, ... Neuro-Oncology 25 (Supplement_1), i45-i46, 2023 | 1 | 2023 |
| IMMU-13. Dual CTLA4/PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study A Das, D Morgenstern, V Bianchi, S Sudhaman, M Edwards, L Stengs, ... Neuro-Oncology 24 (Supplement_1), i84-i84, 2022 | 1 | 2022 |
| Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome H Palova, A Das, P Pokorna, V Bajciova, Z Pavelka, M Jezova, K Pal, ... NPJ Precision Oncology 8 (1), 110, 2024 | | 2024 |
| HiDEF-seq MH Liu, BM Costa, EC Bianchini, U Choi, RC Bandler, E Lassen, ... | | 2024 |
| Replication repair deficient mouse models provide insights into gliomagenesis and response to immunotherapy Z Aamir, M Galati, E Gattoni, O Crump, NM Nunes, A Das, N Fernandez, ... Cancer Research 84 (6_Supplement), 1451-1451, 2024 | | 2024 |
| Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition VJ Forster, M Aronson, C Zhang, J Chung, S Sudhaman, MA Galati, ... NPJ Precision Oncology 8 (1), 69, 2024 | | 2024 |
| The Clinical and Biological Landscape of Constitutional Mismatch Repair Deficiency: An IRRDC Study A Ercan Lancet Oncology, 2024 | | 2024 |
| A validated highly sensitive microsatellite instability assay accurately identifies individuals harboring biallelic germline PMS2 pathogenic variants in Constitutional Mismatch … M Pineda Clinical Chemistry, 2024 | | 2024 |
| TRANS-SPECIES ANALYSIS OF REPLICATION-REPAIR DEFICIENT (RRD) MEDULLOBLASTOMA AND RESPONSE TO IMMUNE-CHECKPOINT INHIBITION: AN IRRDC REPORT A Das, N Fernandez, A Levine, K Smith, E Wang, M Galati, Z Aamir, ... PEDIATRIC BLOOD & CANCER 70, S132-S133, 2023 | | 2023 |
| THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON GLIOMAS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS; A MULTI-CENTRIC, COLLABORATIVE STUDY LED BY THE IRRDC AND GLIOMA TASKFORCE L Negm, J Chung, LF Nobre, J Bennett, N Fernandez, M Komosa, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| IMMU-24. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEFICIENT (RRD) HIGH-GRADE GLIOMA FAILING ANTI-PD1 MONOTHERAPY: A REPORT FROM THE INTERNATIONAL RRD CONSORTIUM A Das, N Fernandez, A Levine, V Bianchi, L Stengs, M Edwards, L Nobre, ... Neuro-Oncology 25 (Supplement_5), v147-v147, 2023 | | 2023 |
| 783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium A Das, N Fernandez, A Levine, V Bianchi, L Stengs, M Edwards, T Pugh, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| IMMU-08. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEFICIENT (RRD) HIGH-GRADE GLIOMA FAILING ANTI-PD1 MONOTHERAPY: AN IRRDC REPORT A Das, NR Fernandez, A Levine, V Bianchi, L Stengs, M Edwards, ... Neuro-Oncology 25 (Suppl 1), i50, 2023 | | 2023 |
| HGG-26. GENOMIC AND IMMUNE ANALYSIS OF PRIMARY REPLICATION-REPAIR DEFICIENT (RRD) GLIOMAS REVEALS THREE SUBGROUPS WITH DISTINCT DRIVERS AND RESPONSE TO IMMUNOTHERAPY: AN IRRDC … NR Fernandez, A Das, A Levine, L Negm, L Nobre, V Bianchi, L Stengs, ... Neuro-Oncology 25 (Suppl 1), i45, 2023 | | 2023 |
Vanessa BianchiThe Hospital for Sick ChildrenVerified email at sickkids.ca
